Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Innovations to accelerate vaccine development and manufacture: call IMI2-2020-20-02

The MIC is a French SME specializing in microfluidic instrumentation and flow control. We would be glad to collaborate with you to design new organ-on-chip in vitro models for the development of new vaccines and share our expertise in H2020 project writing and management. 

Feel free to contact us to start new projects together!

What we can do, as a SME partner

For the call IMI2-2020-20-02, we can bring our expertise in microfluidic instrumentation and flow management to help you develop an organ-on-chip platform to model human mucosa and test new vaccines. 

organ-on-chip_vaccine

Specifically, the MIC can:

  • Propose an organ-on-chip platform to recreate a human mucosa model and test new vaccines;
  • Provide a robust solution for the perfusion of your organ-on-chip device and the injection of complex sequences of media and drugs;
  • Help you to develop a tool that will simplify the access of biologists and pharmacists to this complex though promising technology.

What can organ-on-chip do to accelerate vaccine development?

Organ-on-chip is a very promising tool for developing human in vitro models, and the use of this technology is perfectly aligned with IMI2-2020-21-02 expected impacts, especially those related to subtopic 3 (State-of-art innovations in human in vitro mucosa models and assay):

  • The likelihood of the next-generation in vitro models and assays being incorporated into vaccine development programs on a wider scale and how their potential versatilities and associated guidelines for use will support this incorporation;
    ⇒ Organ-on-chip is a very promising tool for modeling a human body in vitro; however, it often struggles to reach the market because of its complexity. At the MIC, our focus is to make this technology truly accessible for biologists and pharmacists by providing a user-friendly platform specifically designed for this kind of application.
  • In the future, next-generation in vitro models and assays can replace animal testing in research, licensure, and the release of vaccines (with regulatory agency approval).
    ⇒ The cell culture on-chip allows to reproduce very precisely cell microenvironment, in terms of chemicals in contact with the cells, but also regarding the physical parameters (temperature, shear stress imposed on cells, etc…). They are thus much more relevant human models than conventional cell cultures and are excellent candidates to replace animal testing.

The MIC as a lab-on-chip SME partner

Our SME already brought its expertise in droplet microfluidics to several H2020 projects:

droplet generation microdroplets

AutoMonoDroplet

Development of a commercially viable system for the automatic generation of high-throughput, well-defined microdroplets

monodisperse emulsion droplets

AutoDropProd

Automated high-throughput production of monodisperse emulsions with microfluidics

ACDC artificial cell microfluidics Elvesys capsules 300x144

ACDC

Artificial cells with distributed cores to decipher protein function

Check the other Past Calls